Celltrion leads biosimilars deals landscape in South Korea, finds GlobalData EP News Bureau Dec 18, 2024 Celltrion dominates South Korea’s biosimilars landscape, driving deal-making and shaping the global market
Humira biosimilar to see $832 million in sales by 2029: GlobalData EP News Bureau Sep 4, 2023 Humira’s 52-week study evaluated adalimumab’s efficacy and safety for moderate-to-severe psoriasis, exploring continuous against…
o9 Solutions to supply AI-powered IBP platform to Samsung Bioepis EP News Bureau Feb 1, 2021 The platform will be integrated into the client’s existing enterprise resource planning (ERP), seamlessly providing efficiencies…
